FluoroPharma Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Net Income	-2.05	-3.16	-4.13	-5.61	-4.02
Depreciation & Amortization	0.04	0.05	0.04	0.02	0.02
Other Amortization	0.75	0.51	0.04	0.03	-
Loss (Gain) From Sale of Assets	-	-	0.03	-	0
Asset Writedown & Restructuring Costs	-	-	-	0.13	-
Loss (Gain) From Sale of Investments	-	0	0.07	1.05	-
Stock-Based Compensation	0.03	0.17	0.6	0.68	0.87
Other Operating Activities	-1.19	-0.82	-1.24	0.21	-0.13
Change in Accounts Payable	0.32	0.62	0.91	0.05	-0.06
Change in Unearned Revenue	0.41	-	-	-	-
Change in Other Net Operating Assets	0.8	-0.04	0.35	0.1	0.03
Operating Cash Flow	-0.88	-2.68	-3.32	-3.33	-3.28
Capital Expenditures	-0	-0.01	-0.01	-0.01	-0.04
Sale (Purchase) of Intangibles	-	-	-0.35	-	-
Investment in Securities	-	0.04	0.57	1.81	-
Investing Cash Flow	-0	0.03	0.21	1.8	-0.04
Short-Term Debt Issued	0.73	3.35	2.08	0.33	-
Total Debt Issued	0.73	3.35	2.08	0.33	-
Short-Term Debt Repaid	-0.1	-0.49	-0.03	-0.06	-
Total Debt Repaid	-0.1	-0.49	-0.03	-0.06	-
Net Debt Issued (Repaid)	0.63	2.86	2.05	0.28	-
Issuance of Common Stock	-	-	0.29	0.64	1.55
Other Financing Activities	-0.01	-0.17	-0.13	-0.15	-0.19
Financing Cash Flow	0.62	2.69	2.22	1.37	1.36
Net Cash Flow	-0.27	0.04	-0.89	-0.16	-1.96
Free Cash Flow	-0.88	-2.68	-3.33	-3.34	-3.32
Free Cash Flow Per Share	-0.03	-0.09	-0.12	-0.14	-0.15
Cash Interest Paid	0	0	-	0.01	-
Cash Income Tax Paid	0	0	0	0	-
Levered Free Cash Flow	-0.78	-0.97	-2.55	0.81	-1.91
Unlevered Free Cash Flow	-0.74	-0.99	-2.53	0.81	-1.91
Change in Working Capital	1.53	0.58	1.26	0.15	-0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.